Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres

Jens Gottlieb, Martin Kolditz, Nils Gade, Tobias Welte, Nikolaus Kneidinger

Source: Eur Respir J, 60 (1) 2200124; 10.1183/13993003.00124-2022

Journal Issue: July

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jens Gottlieb, Martin Kolditz, Nils Gade, Tobias Welte, Nikolaus Kneidinger. Benefit of monoclonal antibodies in early treatment of COVID-19 after lung transplantation: a retrospective analysis in two centres. Eur Respir J, 60 (1) 2200124; 10.1183/13993003.00124-2022

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.